King Bridge (6133) announced that its shareholder meeting resolved to lift non-compete restrictions on newly appointed independent director Dr. Chou, Hsing-Yi, allowing him to engage in similar business activities during his tenure, with no impact on the company's financials.
AI Analysis
Frequently Asked Questions
Q: What was resolved at King Bridge's shareholder meeting?
A: The resolution lifted non-compete restrictions on independent director Dr. Chou, Hsing-Yi.
Q: What competitive activities is Dr. Chou permitted to engage in?
A: He may engage in businesses similar to King Bridge’s operations during his tenure.
Q: How long is the waiver valid?
A: It remains valid throughout his term as an independent director at King Bridge.
Q: Does this resolution affect King Bridge’s financials?
A: The company stated there is no impact on its financial or business operations.
Q: Does this waiver involve mainland China businesses?
A: No, it explicitly states 'not applicable' regarding mainland China operations.